Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
| Deadline | Title | Funding Agency | Discipline | Who's Eligible | Award Amount |
Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 2/15/2024 | Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3) (Clinical Trial Optional) for Advancing Recruitment through Trial Innovation Network (AR-TIN) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 6/20/2024 | NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/20/2024 | BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/05/2024 | Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/05/2024 | Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,875,000 | 11/10/2023 |
| Deadline: 2/05/2024 | Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/20/2024 | Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/20/2024 | Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/05/2024 | Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/10/2023 |
| Deadline: 2/28/2024 | NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $3,000,000 | 11/09/2023 |
| Deadline: 2/05/2024 | Notice of Special Interest (NOSI): Advancing Research on Early Pregnancy Loss | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/08/2023 |
| Deadline: 2/20/2024 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $750,000 | 11/07/2023 |
| Deadline: 2/20/2024 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $750,000 | 11/07/2023 |
| Deadline: 2/20/2024 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $750,000 | 11/07/2023 |
| Deadline: 2/05/2024 | Notice of Special Interest (NOSI): Respiratory Complications of the Muscular Dystrophies (R01) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/07/2023 |
| Deadline: 2/20/2024 | HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/06/2023 |
| Deadline: 2/21/2024 | Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/06/2023 |
| Deadline: 2/05/2024 | Notice of Special Interest (NOSI): Basic and Translational Research on Circadian Regulation of Heart, Lung, Blood, and Sleep Disorders (R01) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/06/2023 |
| Deadline: 2/05/2024 | Schizophrenia and related disorders during mid- to late-life (R01, R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/06/2023 |
| Deadline: 2/15/2024 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/06/2023 |
